U.S. Home Infusion Therapy Market Analysis

U.S. Home Infusion Therapy Market Analysis

U.S. home infusion therapy market from the infusion pumps product segment will be valued at USD 14 billion by 2032, owing to the growing burden of diabetes in the United States. Devices such as infusion pumps have emerged as preferred care products for diabetes treatment since they can deliver insulin, nutrients, antibiotics, and other fluids in controlled amounts. These benefits, alongside the steady rise in diabetes prevalence, are thus likely to augment service consumption for the controlled administration of medications in diabetic patients.
 

U.S. home infusion therapy market from the anti-infective application segment is poised to depict more than 9.5% CAGR through 2032. This is credited to the rising prevalence of various infectious diseases, including pneumonia, chronic urinary tract infections, cellulitis, catheter sepsis, and abscesses. Most of these patients are opting for anti-infective therapy using infusion devices in homecare facilities, given the product’s ability to be safely managed during diagnosis and treatment. The effectiveness of anti-infective therapy in chronic disease diagnosis and treatment will therefore spur home infusion service adoption in the United States.
 

South Atlantic home infusion therapy market size is anticipated to be worth over USD 6 billion by 2032, on account of the high incidence rate of Alzheimer's disease among older adults. This increase in the Alzheimer’s patient population has increased the adoption of treatments such as home enteral nutrition therapy. Additionally, the increasing per capita income and the prevalence of chronic diseases will accelerate the development of at-home infusion therapy across the region.